Results 171 to 180 of about 3,481 (207)

A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination. [PDF]

open access: yesNPJ Vaccines
Cha I   +13 more
europepmc   +1 more source

Virus envelope glycoprotein targeting bispecific T cell engager protects mice from lethal severe fever with thrombocytopenia virus infection. [PDF]

open access: yesCell Rep Med
Peng X   +21 more
europepmc   +1 more source

A Focus on the Mechanisms of Alteration in Host Lymphocyte Level Following Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Infection. [PDF]

open access: yesJ Inflamm Res
Chen Y   +10 more
europepmc   +1 more source

Co-Circulation of Tick-Borne <i>Bandaviruses</i> and <i>Orthonairoviruses</i> Across Humans, Livestock, and Rats in Pakistan: Serologic Evidence and Public Health Implications. [PDF]

open access: yesViruses
Ammar M   +16 more
europepmc   +1 more source

Epidemic potential of SFTSV: increasing evidence for non-vector-borne transmission

open access: yesThe Lancet Microbe
Wen Zheng   +3 more
openaire   +1 more source

Multi-Epitope mRNA Vaccine Targeting <i>Dabie Bandavirus</i> Glycoprotein: An Immunoinformatics-Based Study. [PDF]

open access: yesBioinform Biol Insights
Ahmed SF   +6 more
europepmc   +1 more source

Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes [PDF]

open access: yesVirologica Sinica, 2020
Severe fever with thrombocytopenia syndrome virus (SFTSV), the causative agent of a febrile human disease, was first identified from central and eastern provinces in China, and later in Japan and South Korea. Hubei Province is one of the major SFTS epidemic areas in the central part of China.
Boyun Liang, Shuang Tang, Hualin Wang
exaly   +3 more sources

Home - About - Disclaimer - Privacy